Announcements Trials
Browse Landscape

Phase

Phase NA 64Phase 2 5Phase 4 3Phase 2/3 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Postoperative Analgesia 1Neoplasms 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Control Groups × Clear all
NCT05149248 2021-12-08

CONDESA

Instituto Nacional de Salud Publica, Mexico

Phase 2/3 Completed
6,000 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT03060070 2017-07-05

Ketamine Versus Dexmedetomidine With Local Anesthetic in TAP Block

Assiut University

Phase 2/3 Completed
90 enrolled

Postoperative Analgesia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡